<bill session="116" type="s" number="3174" updated="2020-09-24T10:45:14Z">
  <state datetime="2020-01-09">REFERRED</state>
  <status>
    <introduced datetime="2020-01-09"/>
  </status>
  <introduced datetime="2020-01-09"/>
  <titles>
    <title type="short" as="introduced">Reversing the Youth Tobacco Epidemic Act of 2020</title>
    <title type="short" as="introduced">Reversing the Youth Tobacco Epidemic Act of 2020</title>
    <title type="display">Reversing the Youth Tobacco Epidemic Act of 2020</title>
    <title type="official" as="introduced">A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the sale and marketing of tobacco products, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="B000944"/>
  <cosponsors>
    <cosponsor bioguide_id="B001277" joined="2020-01-09"/>
    <cosponsor bioguide_id="C000141" joined="2020-01-09"/>
    <cosponsor bioguide_id="C000174" joined="2020-01-13"/>
    <cosponsor bioguide_id="C001088" joined="2020-01-28"/>
    <cosponsor bioguide_id="D000563" joined="2020-01-09"/>
    <cosponsor bioguide_id="H001075" joined="2020-01-09"/>
    <cosponsor bioguide_id="M000133" joined="2020-01-09"/>
    <cosponsor bioguide_id="M001176" joined="2020-01-09"/>
    <cosponsor bioguide_id="R000122" joined="2020-01-09"/>
    <cosponsor bioguide_id="S001181" joined="2020-02-25"/>
    <cosponsor bioguide_id="V000128" joined="2020-06-29"/>
    <cosponsor bioguide_id="W000802" joined="2020-01-09"/>
  </cosponsors>
  <actions>
    <action datetime="2020-01-09">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2020-01-09" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="SSHR" name="Senate Health, Education, Labor, and Pensions" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill type="s" session="116" relation="unknown" number="3223"/>
    <bill type="h" session="116" relation="unknown" number="2339"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Administrative law and regulatory procedures"/>
    <term name="Child health"/>
    <term name="Civil actions and liability"/>
    <term name="Congressional oversight"/>
    <term name="Consumer affairs"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Drug, alcohol, tobacco use"/>
    <term name="Food and Drug Administration (FDA)"/>
    <term name="Government information and archives"/>
    <term name="Government studies and investigations"/>
    <term name="Health care coverage and access"/>
    <term name="Health programs administration and funding"/>
    <term name="Health promotion and preventive care"/>
    <term name="Marketing and advertising"/>
    <term name="Mental health"/>
    <term name="Minority health"/>
    <term name="Racial and ethnic relations"/>
    <term name="Retail and wholesale trades"/>
    <term name="State and local government operations"/>
    <term name="User charges and fees"/>
  </subjects>
  <amendments/>
  <summary date="2020-01-09T05:00:00Z" status="Introduced in Senate">Reversing the Youth Tobacco Epidemic Act of 2019

This bill revises requirements related to the safety, sale, and advertisement of tobacco products, including electronic nicotine delivery systems (e.g., e-cigarettes, e-hookah, e-cigars, and vape pens).

Among other requirements, the bill

 requires the Food and Drug Administration (FDA) to implement regulations to require color graphics on the labeling of cigarette packages, depicting the negative health consequences of smoking; requires the FDA to apply regulations on tobacco products to all tobacco products, including e-cigarettes; prohibits the retail online sale of tobacco products, including electronic nicotine delivery systems; prohibits flavors other than tobacco in a tobacco product; prohibits the use of flavored products in an electronic nicotine delivery system, except in specified circumstances; increases the user fees that the FDA collects from manufacturers and importers; directs the FDA to regulate products containing synthetic nicotine (not made or derived from tobacco); establishes a demonstration grant program to develop strategies for smoking cessation in medically underserved communities; increases civil penalties for certain violations of restrictions on the sale of tobacco products; and requires the Government Accountability Office to study e-cigarettes. &#160;</summary>
  <committee-reports/>
</bill>
